$SHAKESPEAR

When investing from a low level profile, every penny as a loss is a loss that bites. Even when you know a potential ticker will go up, seeing it in the red is bothersome. Needless to say, when you expect or know there is a potential news coming up - there is something to keep in mind. It absolutely does not matter whether the news is good or not. You buy the potential, sell the hype-before-news. The market acts in a very emotional way. People expect good news to come out and buy in, but there are two sides to that coin. The news can be either very good, or very bad. Let's put that into perspective: We will take a pharmaceutical company who has an upcoming drug review. We can use various resources to see that and you can find them listed at the bottom of this post. However, a couple of days prior to this said 'news', you join the flock in loading the stock that is trading at, let's say, $1.00 per share. You expect the shares to skyrocket to $4-5 per share and have put in...

Hey everyone, if some of y'all are wondering why I am posting here on top of Reddit, it is because through this blog, I am able to earn a few bucks. Things have been quite tough through the COVID-19 year and it has hurt a lot. I figured if I post about my research on my own blog and on reddit, then perhaps it would be legitimate way to earn a few bucks. I do not want to make anyone feel like I am clicking baiting them into making money, which is precisely why, the blog here, and reddit are updated simultaneously. If you guys feel like this is not right and I should not post here, then I will not. On top of this, I think the subscribe option on this blog is a way for people to get notified via e-mail whenever I post a DD or a post, which could be helpful if you still are into e-mailing. I heavily am, thank to my work. I hope my posts are helpful and can benefit people! Good luck!

  Hello everyone, welcome to another research, I hope everyone is having a great weekend or will have a great weekend. Please be responsible with your money, this is plain research and please advise me on any mistakes. I am not advising anyone about anything, you are responsible for your own money. With that said, let's take-off! ALL: PLEASE READ THE DISCLAIMER AT THE END OF THIS POST Ticker: XFOR Company Name: X4 Pharmaceuticals Inc. Trading @ ~8.39 Friday close. CNN Money Analysts Link: https://money.cnn.com/quote/forecast/forecast.html?symb=XFOR Price Target: $14 - $23 (low to high) From BioPharmCatalyst & Official Site ( https://www.x4pharma.com/pipeline/pipeline/ ) Upcoming Drugs: Mavorixafor and ibrutinib — Waldenström macroglobulinemia Mavorixafor (X4P-001) — Phase 1/2 Severe Congenital Neutropenia (SCN) Mavorixafor (X4P-001) — Phase 3 WHIM syndrome Drug Pipeline: 4. Mavorixafor and axitinib — Phase 2a Renal Cell Carcinoma (RCC) - cancer *** Note: please review the info...

 Hello all! I hope everyone is doing alright, especially during the pandemic. Many of us have lost loved ones and I think it is important to say that people who are gone will forever be in our memories.  The reason I have chosen to share my research online is because it actually gives me a motive to go the extra mile and look into the stock myself. Sounds like a strange reason? I agree. In the stock market, we do not know what the company is doing and therefore make our actions solely based upon speculation. I view it as an emotional being capable of screwing you over in mere milliseconds... that is faster than you can blink. However, there are tools and data we can utilize to analyze the "mood" (which is price in this case) and secure some profit. It is also worth noting that everything you heard from your childhood about greed is all true here and please do not be me and test it - because you WILL definitely lose it and then wonder if it will ever come back. In my posts, yo...

Ticker: ETTX Company Name: Entasis Therapeutics Holdings Inc. Trading @ 3.11 CNN Money Analysts Link: https://money.cnn.com/quote/forecast/forecast.html?symb=ETTX Price Target: $5 - $9 News: Benzinga: https://www.benzinga.com/pressreleases/21/01/g19317814/entasis-therapeutics-announces-sulbactam-durlobactam-expanded-access-program-for-patients-in-the-u From BioPharmCatalyst & Company Website: https://www.biopharmcatalyst.com/company/ETTX https://www.entasistx.com/pipeline SULBACTAM-DURLOBACTAM (ETX2514SUL) - A multidrug resistant Acinetobacter infections — Phase 3 - Durlobactam (DUR; previously designated ETX2514) is our novel, broad-spectrum and potent inhibitor of Class A, C, and D β-lactamases. Sulbactam (SUL) is a β-lactam antibiotic with activity against Acinetobacter baumannii; however, β-lactamase-mediated resistance to sulbactam is now widespread rendering it generally ineffective. In preclinical studies, durlobactam inhibits the β-lactamases commonly found in...